Metric Finance
LearnFAQ
LearnFAQ

Learn / MGTX

NASDAQ: MGTX

MeiraGTx Holdings plc (MGTX) stock, explained like you're 5

MeiraGTx Holdings plc trades on the Nasdaq under the ticker MGTX. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 1 billion dollars.

Ticker
MGTX
Exchange
Nasdaq
Sector
Healthcare
Industry
Biological Products (No Diagnostic Substances)
Size
Small cap, about 1 billion dollars

Is MeiraGTx Holdings plc a small, medium or large cap company?

No. MeiraGTx Holdings plc is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How MeiraGTx Holdings plc makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves MGTX stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • (MGTX) Movement Within Algorithmic Entry Frameworks (Stock Traders Daily)
  • Can MeiraGTx Holdings PLC (MGTX) Stock Double? Cash Runway Offers a Hint (Yahoo Finance)
  • MeiraGTx (MGTX) Stock Could Look Stretched As Earnings Face Questions (Simply Wall Street)
  • Officer Stuart Naylor proposes selling 27,659 MeiraGTx (NASDAQ: MGTX) shares worth $294K. (Stock Titan)
  • Nine analysts set USD 24.71 target for MeiraGTx stock (ad-hoc-news.de)

Follow MGTX in your daily brief

Each trading day at 5 PM ET we post what happened to MeiraGTx Holdings plc and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow MGTX

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about MeiraGTx Holdings plc stock

What does MeiraGTx Holdings plc do?

MeiraGTx Holdings plc trades on the Nasdaq under the ticker MGTX. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 1 billion dollars.

What is the ticker symbol for MeiraGTx Holdings plc?

MeiraGTx Holdings plc trades under the ticker MGTX on the Nasdaq.

What is MeiraGTx Holdings plc's market cap?

MeiraGTx Holdings plc is a small cap stock with a market cap of about 1 billion dollars.

How does MeiraGTx Holdings plc make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves MGTX stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow MGTX stock every day?

Add MGTX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow MGTX daily

A free brief on MeiraGTx Holdings plc and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • ARGX · Argenx SE
  • RVMD · Revolution Medicines
  • BNTX · BioNTech SE
  • EXEL · Exelixis

Similar stocks

  • ARGXArgenx SE
  • RVMDRevolution Medicines
  • BNTXBioNTech SE
  • EXELExelixis

Compare MGTX: MGTX vs ARGX, MGTX vs RVMD, MGTX vs BNTX

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed